BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25446206)

  • 1. The opioid system contributes to the acquisition of reinforcement for dietary fat but is not required for its maintenance.
    Sakamoto K; Matsumura S; Okafuji Y; Eguchi A; Yoneda T; Mizushige T; Tsuzuki S; Inoue K; Fushiki T
    Physiol Behav; 2015 Jan; 138():227-35. PubMed ID: 25446206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms Involved in Guiding the Preference for Fat Emulsion Differ Depending on the Concentration.
    Sakamoto K; Matsumura S; Okafuji Y; Eguchi A; Lee S; Adachi S; Fujitani M; Tsuzuki S; Inoue K; Fushiki T
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(3):247-54. PubMed ID: 26226962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opioid system majorly contributes to preference for fat emulsions but not sucrose solutions in mice.
    Sakamoto K; Okahashi T; Matsumura S; Okafuji Y; Adachi S; Tsuzuki S; Inoue K; Fushiki T
    Biosci Biotechnol Biochem; 2015; 79(4):658-63. PubMed ID: 25516200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions.
    Corwin RL; Wojnicki FH
    Behav Pharmacol; 2009 Sep; 20(5-6):537-48. PubMed ID: 19724193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition and expression of fat conditioned flavor preferences following dopamine D1, opioid and NMDA receptor antagonism in C57BL/6 mice.
    Iskhakova J; Mustac T; Yuabov A; Macanian J; Israel E; Dohnalova P; Iskhakov B; Lulu EB; Aminov S; Fazylov D; Bodnar RJ
    Nutr Neurosci; 2022 Jan; 25(1):137-145. PubMed ID: 32050863
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic variance contributes to dopamine and opioid receptor antagonist-induced inhibition of intralipid (fat) intake in inbred and outbred mouse strains.
    Dym CT; Bae VS; Kraft T; Yakubov Y; Winn A; Sclafani A; Bodnar RJ
    Brain Res; 2010 Feb; 1316():51-61. PubMed ID: 20026311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1 and opioid receptor antagonism effects on the acquisition and expression of fat-conditioned flavor preferences in BALB/c and SWR mice.
    Kraft TT; Yakubov Y; Huang D; Fitzgerald G; Acosta V; Natanova E; Touzani K; Sclafani A; Bodnar RJ
    Pharmacol Biochem Behav; 2013 Sep; 110():127-36. PubMed ID: 23831446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AM 251 and beta-Funaltrexamine reduce fat intake in a fat-preferring strain of mouse.
    South T; Deng C; Huang XF
    Behav Brain Res; 2007 Jul; 181(1):153-7. PubMed ID: 17475345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditioned place preferences (CPPs) to high-caloric "snack foods" in rat strains genetically prone vs. resistant to diet-induced obesity: resistance to naltrexone blockade.
    Jarosz PA; Kessler JT; Sekhon P; Coscina DV
    Pharmacol Biochem Behav; 2007 Apr; 86(4):699-704. PubMed ID: 17391743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of baclofen and naltrexone, alone and in combination, on the consumption of palatable food in male rats.
    Avena NM; Bocarsly ME; Murray S; Gold MS
    Exp Clin Psychopharmacol; 2014 Oct; 22(5):460-7. PubMed ID: 25069013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of sucrose-reinforced place-preference conditioning: effects of naltrexone.
    Delamater AR; Sclafani A; Bodnar RJ
    Pharmacol Biochem Behav; 2000 Apr; 65(4):697-704. PubMed ID: 10764925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D1 and opioid receptor antagonists differentially reduce the acquisition and expression of fructose-conditioned flavor preferences in BALB/c and SWR mice.
    Kraft TT; Yakubov Y; Huang D; Fitzgerald G; Natanova E; Sclafani A; Bodnar RJ
    Physiol Behav; 2015 Nov; 151():213-20. PubMed ID: 26220464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat.
    Häggkvist J; Lindholm S; Franck J
    Behav Brain Res; 2009 Jan; 197(1):219-24. PubMed ID: 18793682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition and expression of fat-conditioned flavor preferences are differentially affected by NMDA receptor antagonism in BALB/c and SWR mice.
    Kraft TT; Huang D; LaMagna S; Warshaw D; Natanova E; Sclafani A; Bodnar RJ
    Eur J Pharmacol; 2017 Mar; 799():26-32. PubMed ID: 28132914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of NMDA but not opioid receptors in the acquisition of fat-conditioned flavor preferences in rats.
    Dela Cruz JA; Bae VS; Icaza-Cukali D; Sampson C; Bamshad D; Samra A; Singh S; Khalifa N; Touzani K; Sclafani A; Bodnar RJ
    Neurobiol Learn Mem; 2012 Nov; 98(4):341-7. PubMed ID: 23103774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone effects on ethanol reward and discrimination in C57BL/6 mice.
    Middaugh LD; Kelley BM; Cuison ER; Groseclose CH
    Alcohol Clin Exp Res; 1999 Mar; 23(3):456-64. PubMed ID: 10195818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleus accumbens opioid signaling conditions short-term flavor preferences.
    Woolley JD; Lee BS; Taha SA; Fields HL
    Neuroscience; 2007 Apr; 146(1):19-30. PubMed ID: 17320293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of μ-opioid receptors reduces sensation seeking-like behavior in mice.
    Sikora M; Skupio U; Jastrzebska K; Rodriguez Parkitna J; Przewlocki R
    Behav Brain Res; 2019 Feb; 359():498-501. PubMed ID: 30500427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating.
    Giuliano C; Robbins TW; Nathan PJ; Bullmore ET; Everitt BJ
    Neuropsychopharmacology; 2012 Nov; 37(12):2643-52. PubMed ID: 22805601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the opioid μ1, but not δ or κ, receptors is required for nicotine reinforcement in a rat model of drug self-administration.
    Liu X; Jernigan C
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):146-53. PubMed ID: 20965223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.